What is Alirocumab: Uses, Dosage, Side Effects and More

Alirocumab is a prescription medication that helps lower your cholesterol levels when diet and exercise aren't enough. It's a powerful tool that works differently from traditional cholesterol medications like statins, offering hope for people who need extra help managing their heart health.

This medication belongs to a newer class of drugs called PCSK9 inhibitors, and it comes as an injection you give yourself under the skin. While the idea of self-injecting might feel overwhelming at first, many people find it becomes a simple part of their routine with proper guidance from their healthcare team.

What is Alirocumab?

Alirocumab is a man-made antibody that targets a specific protein in your body called PCSK9. Think of it as a specialized helper that works with your liver to remove more cholesterol from your bloodstream.

Unlike statins that work inside your liver cells, alirocumab works outside the cells by blocking PCSK9 protein. This protein normally prevents your liver from clearing cholesterol effectively. When alirocumab blocks it, your liver can do a much better job of removing the "bad" LDL cholesterol from your blood.

The medication comes as a clear, colorless solution in a pre-filled pen or syringe. It's designed for subcutaneous injection, which means you inject it into the fatty tissue just under your skin, similar to how people with diabetes inject insulin.

What is Alirocumab Used For?

Alirocumab is primarily used to lower LDL cholesterol (the "bad" cholesterol) in adults who need extra help beyond diet, exercise, and other cholesterol medications. Your doctor might prescribe it if you have familial hypercholesterolemia, a genetic condition that causes very high cholesterol levels.

It's also prescribed for people who have established cardiovascular disease and need to reduce their risk of heart attacks, strokes, or other serious heart problems. This includes patients who've already had a heart attack, stroke, or certain types of chest pain called unstable angina.

The medication is typically reserved for people who haven't reached their cholesterol goals with maximum tolerated statin therapy. Some people can't take statins due to side effects like muscle pain, and alirocumab offers an alternative path to better cholesterol control.

How Does Alirocumab Work?

Alirocumab is considered a strong cholesterol-lowering medication that works through a sophisticated mechanism. It's a monoclonal antibody that specifically targets and binds to the PCSK9 protein in your bloodstream.

Here's how it helps your body: Your liver has special receptors that grab cholesterol from your blood and break it down. The PCSK9 protein acts like a troublemaker, destroying these helpful receptors. When alirocumab blocks PCSK9, more receptors survive and can continue removing cholesterol from your blood.

This process can lower your LDL cholesterol by 45-60% or even more in some people. The effects are quite powerful and can be seen within a few weeks of starting treatment. Unlike some medications that work gradually, alirocumab provides relatively quick and significant cholesterol reduction.

How Should I Take Alirocumab?

Alirocumab is given as an injection under your skin every two weeks. The standard dose is 75 mg, though your doctor might increase it to 150 mg if needed. You'll inject it into your thigh, upper arm, or abdomen, rotating the injection sites to prevent skin irritation.

You can take this medication with or without food since it's injected rather than swallowed. However, it's important to let the medication reach room temperature before injecting. Take it out of the refrigerator about 15-40 minutes before your injection time.

Your healthcare provider will teach you the proper injection technique during your first visit. The pre-filled pen makes the process straightforward, but proper training ensures you're comfortable and confident with each injection. Many people find it helpful to set a regular day and time for their injections to maintain consistency.

How Long Should I Take Alirocumab For?

Alirocumab is typically a long-term treatment that you'll continue as long as it's helping your cholesterol levels and your doctor recommends it. Most people take it for years rather than months, as high cholesterol is usually a chronic condition that requires ongoing management.

Your doctor will monitor your cholesterol levels regularly, usually checking them after 4-8 weeks of treatment and then every few months. These tests help determine whether the medication is working effectively and whether any dose adjustments are needed.

The duration of treatment depends on your individual situation, including your cholesterol levels, heart disease risk, and how well you respond to the medication. Some people might be able to reduce their dose over time, while others may need to continue the same regimen indefinitely.

What Are the Side Effects of Alirocumab?

Most people tolerate alirocumab well, but like all medications, it can cause side effects. The most common side effects are generally mild and manageable with proper care and monitoring.

Here are the more common side effects you might experience:

• Injection site reactions like redness, swelling, or tenderness
• Cold-like symptoms including runny nose or sore throat
• Flu-like symptoms such as fatigue or muscle aches
• Itching or skin rash
• Urinary tract infections
• Diarrhea or stomach upset

These side effects often improve as your body adjusts to the medication. Rotating injection sites and proper injection technique can help minimize skin reactions.

While less common, some people may experience more serious side effects that require immediate medical attention:

• Severe allergic reactions with difficulty breathing, swelling of face or throat
• Persistent muscle pain or weakness
• Signs of liver problems like yellowing skin or eyes
• Severe injection site reactions that don't improve

Contact your healthcare provider if you experience any concerning symptoms or if side effects interfere with your daily life.

Who Should Not Take Alirocumab?

Alirocumab isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you. People with known allergies to alirocumab or any of its ingredients should avoid this medication.

Your doctor will be particularly cautious if you have a history of severe allergic reactions to other medications or if you have certain medical conditions. Pregnant women shouldn't take alirocumab unless the potential benefits clearly outweigh the risks, as its effects on developing babies aren't fully known.

If you're breastfeeding, discuss this with your doctor, as it's unclear whether the medication passes into breast milk. People with severe kidney or liver disease may need special monitoring or dose adjustments.

Children and teenagers typically shouldn't take alirocumab unless they have severe familial hypercholesterolemia and other treatments haven't worked. The safety and effectiveness in pediatric patients are still being studied.

Alirocumab Brand Names

Alirocumab is sold under the brand name Praluent in the United States and many other countries. This is the most common name you'll see on prescriptions and in pharmacies.

The medication is manufactured by Regeneron Pharmaceuticals and Sanofi, and it's available only as a brand-name drug. Currently, there's no generic version of alirocumab available, which means it can be quite expensive without insurance coverage.

Some insurance plans may require prior authorization before covering Praluent, and your doctor may need to demonstrate that other cholesterol medications haven't been effective for you.

Alirocumab Alternatives

If alirocumab isn't right for you, several other options can help manage your cholesterol levels. Evolocumab (Repatha) is another PCSK9 inhibitor that works similarly to alirocumab but might be better tolerated by some people.

Traditional statin medications like atorvastatin (Lipitor) or rosuvastatin (Crestor) remain the first-line treatment for most people with high cholesterol. These oral medications are generally effective and much less expensive than PCSK9 inhibitors.

Other alternatives include ezetimibe (Zetia), which blocks cholesterol absorption in your intestines, and bile acid sequestrants like cholestyramine. For people with very high triglycerides, medications like icosapent ethyl (Vascepa) might be helpful.

Newer options include bempedoic acid (Nexletol) and inclisiran (Leqvio), which work through different mechanisms to lower cholesterol. Your doctor will help you find the best combination of treatments based on your specific needs and circumstances.

Is Alirocumab Better Than Evolocumab?

Both alirocumab and evolocumab are PCSK9 inhibitors that work similarly and have comparable effectiveness in lowering cholesterol levels. Studies show both medications can reduce LDL cholesterol by 50-60% or more when added to statin therapy.

The choice between them often comes down to individual factors like side effect profiles, dosing schedules, and insurance coverage. Alirocumab is typically given every two weeks, while evolocumab can be given every two weeks or monthly, depending on the dose.

Some people might tolerate one better than the other, and your doctor might switch medications if you experience side effects. Both have similar safety profiles, but individual responses can vary.

Cost and insurance coverage often play a significant role in the decision, as both medications are expensive. Your doctor and pharmacist can help you navigate these practical considerations while ensuring you get effective cholesterol management.